Michael D. Gillett

Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.

J. Cheville, R. Thompson, C. Lohse, 2004, Proceedings of the National Academy of Sciences of the United States of America.

618: Costimulatory B7-H1 In Renal Cell Carcinoma Patients: Indicator of Tumor Aggressiveness and Potential Therapeutic Target

J. Cheville, R. Thompson, C. Lohse, 2005 .

Costimulatory molecule B7‐H1 in primary and metastatic clear cell renal cell carcinoma

J. Cheville, R. Thompson, C. Lohse, 2005, Cancer.

Should the upper tracts be imaged for microscopic haematuria?

J. Hentz, M. Feldstein, D. Novicki, 2005, BJU international.

Differences in organ system of distant metastasis by renal cell carcinoma subtype.

J. Cheville, C. Lohse, B. Leibovich, 2008, The Journal of urology.

Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.

J. Cheville, C. Lohse, B. Leibovich, 2005, The Journal of urology.

Case report: Intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend®)

J. Sprung, D. Matesic, E. Frigas, 2006, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

Costimulatory B 7-H 1 in renal cell carcinoma patients : Indicator of tumor aggressiveness and potential therapeutic target

J. Cheville, R. Thompson, C. Lohse, 2004 .

Split-thickness skin graft for the management of concealed penis.

D. Husmann, S. A. Kramer, R. Clay, 2005, The Journal of urology.

Tissue ablation technologies for localized prostate cancer.

Matthew T Gettman, M. Blute, M. Gettman, 2004, Mayo Clinic proceedings.